| Product NDC: | 65649-102 |
| Proprietary Name: | GIAZO |
| Non Proprietary Name: | balsalazide disodium |
| Active Ingredient(s): | 1.1 g/1 & nbsp; balsalazide disodium |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 65649-102 |
| Labeler Name: | Salix Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022205 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20120202 |
| Package NDC: | 65649-102-02 |
| Package Description: | 180 TABLET, FILM COATED in 1 BOTTLE (65649-102-02) |
| NDC Code | 65649-102-02 |
| Proprietary Name | GIAZO |
| Package Description | 180 TABLET, FILM COATED in 1 BOTTLE (65649-102-02) |
| Product NDC | 65649-102 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | balsalazide disodium |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20120202 |
| Marketing Category Name | NDA |
| Labeler Name | Salix Pharmaceuticals, Inc. |
| Substance Name | BALSALAZIDE DISODIUM |
| Strength Number | 1.1 |
| Strength Unit | g/1 |
| Pharmaceutical Classes | Aminosalicylate [EPC],Aminosalicylic Acids [Chemical/Ingredient] |